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Summary 
To  assess the  sensitivity of B  cell tolerance  with  respect  to  receptor/autoantigen  affinity,  we 
identified low affinity ligands to the 3-83  (anti-major histocompatibility complex class I) anti- 
body and tested the ability of these ligands to induce  central and peripheral tolerance in 3-83 
transgenic  mice.  Several  class I protein  aUoforms,  including K bin3 and D k, showed remarkably 
low, but detectable, affinity to 3-83. The 3-83 antibody bound K b with K A "-'2 ×  105 M-1 and 
bound  10-fold more weakly to the K bin3 (K  A "-'2  ×  104 M -1) and D k antigens. Breeding 3-83 
immunoglobulin  transgenic  mice  with  mice  expressing  these  ultralow  affinity  m bm3  and  D k 
ligands  resulted in virtually complete  deletion  of the  autoreactive B  cells from the peripheral 
lymphoid tissues. These low affinity antigens also induced receptor editing, as measured by ele- 
vated RAG mR.NA levels in the bone marrow and excess levels of id- variant B cells bearing 
light chains in the spleen. Reactive class I antigens were also able to mediate deletion of mature 
B  cells when injected into the peritoneal cavity of 3-83 transgenic mice. Although the highest 
affinity ligand,  K k, was consistently able to  induce  elimination  of the 3-83  peritoneal B  cells, 
the lower affinity ligands were  only partially effective.  These results demonstrate  the remark- 
able sensitivity of the deletion and receptor-editing mechanisms in immature B  cells, and may 
suggest a higher affinity threshold for deletion of peripheral, mature B  cells. 
S  elf/nonself discrimination is initiated by antigen recep- 
tor engagement,  but,  unlike other receptor/ligand  sys- 
tems, the antigen receptors do not have predefined ligands. 
It is therefore  important  to understand  how  antigen form, 
affinity, and avidity affect activation and subsequent biolog- 
ical consequences,  including tolerance.  In B  cells, multiple 
tolerance mechanisms appear to work together to maintain 
control  of autoreactivity (reviewed in  1-6).  These mecha- 
nisms,  including  central  deletion  (7-11),  receptor  editing 
(12-16),  anergy  (17-19),  folhcular  exclusion  (19,  20),  pe- 
ripheral  deletion  of resting B  cells  (21-26),  and  antigen- 
and Fas- mediated death of germinal center B cells (27-30), 
have  been  described.  Importantly,  the  affinity  and  avidity 
of the antigen/B  cell reeptor  (BC1K)  1 interaction  may de- 
termine  extent of tolerance  induction,  as well as tolerance 
phenotype (1, 31-36). 
Tolerance susceptibility and mechanisms are also affected 
by the developmental stage at which the auto:-eactive B cell 
IAbbreviations used in  this paper: BCP,, B cell receptor; RU,  resonance 
units. 
encounters  antigen.  In  adult  mice,  the  initial antigen-spe- 
cific negative selection step in B cell development occurs in 
the bone marrow through a process of developmental arrest 
(37)  associated  with  ongoing  light  chain  gene  rearrange- 
ment that can alter BCR specificity, a process referred to as 
receptor editing  (12-16).  B  cells encountering self-antigen 
later in development can be controlled by a number of other 
mechanisms,  all  of which  accelerate  B  cell death  (21-30). 
To  evaluate  the  relative  significance  of the  various  B  cell 
tolerance mechanisms in controlling autoreactive B  cells, it 
is  important  to  determine  the  sensitivity  of these  mecha- 
nisms to BCP,/antigen affinity. Here, we test the hypothe- 
sis that cell-surface antigens with very low affinity for BC1L 
might fail to mediate central or peripheral tolerance. 
Materials  and  Methods 
Mice.  The 3-83 ~/8 transgemc mice (21), which express IgM 
and IgD forms of the 3-83 antibody, were bred and maintained in 
the animal care facility at the National Jewish Center for Immu- 
nology  and  Respiratory  Medicine  (NJCIR.M).  3-83  1~/8 mice 
were backcrossed  a minimum of 10 times onto a B10.D2 back- 
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J-H-2bm3/EgAoEg (H-2bm3), C57B1/6 bin6 (H-2bm6), C57B1/6 Kh- 
H-2bmS/KhEg  (H-2bmS), B6.C-H-2bmil/KhEg  (H-2bm11), C3H- 
H-2°2/SfSn  (C3H.OH:  KaDk),  B10.M/Sn  (H-2f),  B10.BR/Sg- 
SnJ  (H-2k),  C57B1/6  (H-2b),  and B10.D2/nSnJ  (H-2 a)  mice  (all 
purchased  from Jackson  Laboratory, Bar  Harbor,  ME).  The F1 
mice  were  directly  analyzed.  Initial  screening  for  low  affinity 
ligands was performed on H-2  bm~,3,4,8,9,m,11 mice, kindly provided 
by Dr. Roger Melvold (Northwestern University Medical School, 
Chicago,  IL).  132-microglobulin-deficient mice were a generous 
gift from Beverly Koller (University of North  Carolina,  Chapel 
Hill, NC)  (38).  These mice were crossed with B10.D2 3-83 trans- 
genics.  The  F1  mice  were  interbred  to  obtain  3-83  Ix/8  trans- 
genic,  ~2-microglobulin -/-  mice  on a H-2 a homozygous back- 
ground. These resulting mice were analyzed as negative controls. 
Cell Lines.  Sp2/0-derived  H-2  b and  H-2  b mutant  cell  lines 
(bin3,  bin5,  bin8,  and  bmll)  were  a  generous  gift  from Janko 
Nikolic-Zugic and MJ. Bevan (formerly at The Scripps Research 
Institute,  La  Jolla,  CA)  (39).  The  4549  (H-2  k)  cell  line  was 
obtained  from  L.  Wysocld  (NJCI1KM).  The  Sp2/0  (H-2  a)  cell 
line  (40)  was  purchased  from American Type Tissue  Collection 
(Rockville, MD). 
Antibodies and Immunofluorescence.  Lymphoid  cells  were  pre- 
pared as described previously (7),  and were stained with the fol- 
lowing mAbs:  anti-3-83  clonotype, 54.1/biotin  (7),  anti-B220/ 
FITC,  RA3-3A1  (41);  anti-IgM/biotin,  Ak2,  33.24.12  (42); 
anti_H_2Kk,b.m~ta~,t  .... s,q,  Dk/biotin,  Y3  (43)  and 3-83P  (44);  anti- 
mouse  IgD  ~,  AMS  9.1/biotin  (45),  (Pharmingen,  San  Diego, 
CA);  and  anti-IgM~/FITC,  P,  S3  (46);  and  with  the  following 
polyclonal  antibodies:  rat  anti-mouse  IgM,  LO-MM-9/FITC 
(47),  (Zymed Laboratories,  South San Francisco,  CA);  and goat 
anti-h/FITC  (Fisher  Scientific,  Pittsburgh,  PA).  Biotin-conju- 
gated  antibodies  were  revealed  with  PE-streptavidin  (Becton 
Dickinson &  Co,  Mountain View,  CA).  Samples were analyzed 
on  a  FACScan  ® (Becton Dickinson),  FACS  ® Profile,  or Profile 
ELITE  (Coulter Electronics  Inc.,  Hialeah,  FL).  Purification  and 
fluorochrome  conjugation  of the  antibodies were  performed  as 
described previously (48). Except for the cell-staining binding as- 
says,  histogram analysis data were gated by side scatter to include 
the predominant lymphocyte population. 
Class I Molecules.  Soluble  K b and  K bin3 were  purified  as  de- 
scribed  previously  (49).  Briefly,  Drosophila $2/M3  cells  were 
cotransfected with a soluble form of H-2K  b or K bin3 cDNA and a 
full-length  cDNA  encoding  murine  [32m.  Stable  transfectants 
grown  in  serum-free  medium  were  induced  by  cupric  sulfate 
(0.7 mM).  Culture supernatants were collected by centrifugation 
and concentrated. Soluble K b was purified on an anti-K  b, bin3 (Y3) 
affinity column and the His-tagged K i'm3 was purified on a nickel 
column, both of which were followed by ion-exchange chroma- 
tography. Approximate yields were 0.5 mg H-2K/liter of super- 
natant.  The  K b  and  K bin3 were  concentrated,  dialyzed  against 
PBS, filter sterilized, and stored at 4°C. 
Fat  , Preparation.  Fab fragments of the 3-83 antibody were pre- 
pared using the ImmunoPure Fab Preparation Kit (Pierce Chemi- 
ca3 Co.,  Rockford,  IL). Fab preparations were verified on reduc- 
ing  and  nonreducing  SDS-polyacrylamide  gels.  Specifity  of F~b 
fragments  was  verified  upon  biotinylation  of the  Fab  fragments, 
followed by staining of H-2 K k cells and flow cytometry analysis 
as described above. 
Affinity Measurements.  Kinetic measurements were made with 
surface plasmon resonance apparatus (BIAcore; Pharmacia, Piscat- 
away,  NJ).  Proteins to be coupled to the sensor chip were con- 
centrated  using  Centricon-10  microfuge  tubes  (W.IL.  Grace  & 
Co.,  Beverly,  MA),  washed  twice,  and  resuspended  in  10-raM 
Na-acetate, pH 5.0, to a concentration of,'-,50 txg/ml for soluble 
K b, and 20 txg/ml for all antibodies. The K bin3 molecules were re- 
suspended  in  10  mM  morpholino  propane  sulfonic  acid buffer, 
pH 6.0, to a concentration of 20 ~g/ml. Ligands were covalently 
bound to the sensor chips using the BIAcore  TM  Amine Coupling 
Kit  (Pharmacia  Biosensor),  according  to  the  manufacturer's  in- 
structions.  The  amount  of protein  bound  to  the  CM5  sensor 
chips was as follows: chip 1: K b (3421 resonance units [1KU]); chip 
2:Y3  (6854 RU),  3-83  (7236 FLU), and Hopc-1  (50)  (purchased 
from American Type Culture Collection; 6123 RU); chip 3:54.1 
(3671  FLU),  K b  (2821  RU),  and  33.18.12  (42)  (anti-mouse  K; 
2458  FLU);  chip  4:  K bm3-'~v (3246  FLU),  K bm3  (3864  RU),  and 
54.1  (2188  RU);  chip  5:3-83  (6667  FLU)  and  Hopc-1  (5364 
RU).  Analyte solutions were  diluted in  running buffer  (PBS,  1 
mM EDTA, 0.05% P20 BIAcore  TM or 1:1,000 Triton-X 100 sur- 
factant)  to the following concentration ranges representing two- 
fold dilutions: run  1 (chip  1): 3-83  (25-800 riM)  over Kb; run 2 
(chip 2): soluble K b over Y3  (62-500 nM), 3-83  (62-1,000 nM), 
and Hopc-1  (62-1,000  riM);  run  3  (chip  3):  3-83  IgG (25-800 
nM),  3-83  Fab  (250-8,000  nM),  Y3  IgG  (62-200  nM),  and 
Hopc-1  (25-800 nM) over Kb; run 4  (chip 2): soluble K bin3 (39- 
625  riM),  K bin3  ....  (125-500  nM)  over Y3  and  Hopc-1;  run  5 
(chip  5):  soluble  K bin3 (32--4,140  nM)  and  m  bin3  ....  (143-9,140 
nM)  over 3-83  and  Hopc-1;  run  6  (chip  4):  3-83  IgG  (25nM) 
over 54.1; and run 7 (chip 4): 3-83 IgG (59-1,875 nM), 3-83 Fab 
(96-24,450  nM),  and  Hopc-1  (109-3500  nM)  over  K b'''3-+wv. 
Since initial experiments showed a probability of aggregated anti- 
bodies, the antibody preps were spun at 100,000 g for 45 rain im- 
mediately before dilution and passage over the K bin3 bound sensor 
chips.  Each analyte preparation was  injected over the  covalently 
bound ligand on the BIASensor chip at a flow rate of 15-25  t*1/ 
rain for 2 rain.  The analyte was allowed to dissociate with buffer 
for adequate  time to  remove analyte from the chip  (5-60  min). 
For binding  of IgG Y3  antibody  to  K b,  3-83  IgG to  54.1,  and 
3-83 Fab to 33.18.12,  the dissociation rate was too slow to com- 
pletely remove all analyte. For this reason, kinetic  data was lim- 
ited to the first injection only. The experiments with soluble K b 
were performed on the BIACore  1000,  which allows passage of 
analyte  over  a  single  flowcell  (single  protein  bound  to  chip), 
while  the  K  bin3  experiments  used the BIACore  2000,  which  al- 
lows flow of ana3yte over all four flowcells on a single chip in se- 
ries. The BIACore 2000 has the added advantage of lower signal/ 
noise  ratio  and  higher  sensitivity,  measuring  affinities  as  low  as 
104 M -1, while the BIACore 1000 has limitations in the 10  s M- 
range. 
Data sensograms (showing relative FLU changes caused by in- 
jection,  buffer changes,  and binding of ligand)  were  analyzed to 
calculate association and dissociation rate constants using the B IA- 
Evaluation 2.0 program and time points relevant to  the associa- 
tion  and  dissociation phases,  excluding  the  first  few  seconds  of 
each  phase  from  analysis to  avoid  buffer  and  mass  transport ef- 
fects.  The dissociation rate constant  (ka) was determined initially 
by the AB  =  A  +  B  regression model to fit slope of ln(R0/R) vs. 
time plot. Because of steepness of the slope and the short length 
of dissociation period, this method proved inacurrate for instances 
of very fast offrates. Therefore, the half-life of bound protein was 
determined  by  subtracting  the  initial  time  of dissociation phase 
from the time at which half of the bound protein was dissociated. 
The amount of protein bound was calculated as the maximal FLU 
of sensogram over experimental chip minus maximal FLU of same 
analyte over a blank or irrelevant protein chip.  The kd was then 
calculated as 0.693/t  1/2  (s-l)  and averaged over several concen- 
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was calculated by both the A  +  B  =  AB type 1 and 4 options of 
the BIAEvaluation program. The first model is a regression analy- 
sis for first-order kinetic reactions and assumes a known ka. The 
data from this analysis showed large variations, with the k  a value 
decreasing with concentration. The second method, referred to as 
the lq vs.  concentration method, does not assume k a values, and 
calculates ka based on several concentrations of analyte. For each 
concentration of analyte, the program determines the slope (k,) of 
dR/dt vs.  R.  The association constant was then calculated as the 
negative slope of lq vs.  concentration.  The  Ka value determined 
by the  k~ vs.  concentration method correlated well with  the Ka 
calculated by the regression analysis for the highest analyte con- 
centration. BIACore kinetic analysis is considered most accurate 
in cases where the least free ligand is available for rebinding (51). 
This occurs at high concentrations of analyte. Because of the very 
low affinity binding,  the data were difficult to interpret in some 
experiments.  The  ks  vs.  concentration  method  did  not  always 
generate a straight line, and in these cases, analysis for k~ was re- 
stricted to the regression analysis. Also in instances where analyte 
dissociated very slowly, analyses of both k d and k~ were restricted 
to  the  regression  models  for  the  first  concentration  of analyte 
tested.  The  equilibrium association constant  (Ka)  was  calculated 
as the dividend of k~ over k  d. 
Detection ofmRNA.  The levels of G~,  RAG-l,  and RAG-2 
mRNA expression in the bone marrow ofF1  mice were detected 
using  reverse transcription-PCR  and  Southern  analysis,  and  the 
quantitation  of radioactive  signals  was  performed  as  described 
previously (13). 
IntraperitoneaI Injection Assays.  Sp2/0  hybridomas  derived from 
bm mutant spleen cells (39), in addition to Sp2/0 (H-2 d) antigen- 
negative control cells,  were washed twice in sterile PBS and re- 
suspended at 5.0 X  10Vcells/ml. Using 26-gauge needles, 100 ~tl/ 
mouse of hybridoma cells were injected into the peritoneums of 
age-matched,  nondeleting  (H-2 d background)  3-83  hemizygous 
transgenic mice. One mouse from each group received 100 la.1 of 
PBS  alone.  Approximately  16  h  later,  the mice were killed and 
the peritoneal cells were removed by flushing with  10 ml of ei- 
ther  HBSS  or  PBS.  In  some  experiments,  the  lymph  nodes, 
spleen, and/or bone marrow were also analyzed. The peritoneal 
cells were centrifuged, treated with either Gey's solution or buf- 
fered  ammonium  chloride  to  remove  red  blood  cells,  washed 
twice in staining buffer, counted, and stained. Samples were ana- 
lyzed  on  either the  Profile  or ELITE  flow cytometers  (Coulter 
Electronics).  To  exclude  the larger, injected tumor ceils,  detec- 
tion  of idiotype-positive  B  ceils was  limited to  the  lymphocyte 
population,  as defined by forward and side scatter. Detection of 
class I molecules by Y3 antibodies was analyzed for both the small 
lymphocytic and larger, tumor-containing myeloid populations. 
Results 
3-83 Antibody  Cross-reacts  Weakly to t~ and Natural Muta- 
tions in the t(  ° Molecule Further Lower the Relative Binding Af- 
finity.  The  3-83  antibody was raised in a BALB/c  (H-2 d) 
mouse by immunization with C3H  (H-2 k) spleen cells, and 
has specificity for K k, but also binds very weaHy to D k and 
to  other alloforms of H-2 k (44).  Relative rankings  of 3-83 
affinities  to  various  class  I  molecules  were  determined  by 
flow cytometry  (Fig.  1).  Cross-reactive binding  of 3-83  to 
K b cells required far higher concentrations of antibody rela- 
tive  to  that  required  for  comparable  binding  to  K k  cells 
(reference 44  and Fig.  1 A).  Despite  the  relatively low af- 
finity for K b, 3-83 ix/~ Ig transgenid mice bred onto a H-2 b 
background  completely  deleted  the  autoreactive  B  cells 
from  secondary  lymphoid  organs  (13,  21,  34),  indicating 
that this weak binding is physiologically relevant. 
Natural mutants of the K b molecule,  the so-called "bin" 
series  (52),  had  further  reduced  affinity  to  the  3-83  anti- 
body,  relative  to  K b.  Spleen  and  lymph  node  cells  of 
H-2 bm1'3'4'8'9'I0'1I  strains  were  analyzed  directly  for  relative 
binding to 3-83  in complement-mediated cytotoxicity and 
flow  cytometry  assays.  All  target  cells  tested,  except  bml, 
had lower binding to 3-83  than to the natural K b molecule 
(not shown).  Hybridomas  derived from bm mutant spleen 
cells (39) were stained with 3-83  (Fig.  1 A)  or the mAb Y3 
(Fig.  1 /3), which recognizes the same epitope on H-2K  k as 
that  seen  by  3-83  (53).  All  antigen-beating  cells  showed 
similar levels of class I expression,  as detected by Y3 bind- 
ing.  Mutations  in  g  bm3  reduced  3-83  binding  (Fig.  1  A), 
but  not  Y3  binding  (Fig.  1  B).  Staining  of" lymphocytes 
from mice homozygous  at the H-2 locus for the K b muta- 
tions  confirmed  these results  (Fig.  1,  C  and D).  When  re- 
acted  with  3-83  antibody,  K bm3  was  bound  less  well  than 
K b,  whereas  both  were  bound  similarly  by  the  Y3  anti- 
body.  The  reactivity  of 3-83  to  the D k molecule  was  also 
much  weaker than  its  cross-reactivity to  the  K b molecule. 
When  the  data  are  corrected  for nonspecific  binding,  it  is 
apparent that the very low affinity ligands  K bm3  and D k re- 
quired >  10-fold higher concentrations of 3-83 to achieve a 
level of binding comparable  to  that observed with  K b cells 
(Fig.  1,  A  and  D).  Thus,  flow  cytometry  was  useful  in 
identifying  and  ranking  the  relative  binding  strength  of 
ligands  that  were  very  weakly  reactive  to  the  3-83  anti- 
body. 
The 3-83 Antibody Binds the Intermediate Ad~inity Ligand IC  ° 
with an Association Constant in the 10  s M-i Range.  Using  the 
technique of surface plasmon resonance  (54,  55),  the equi- 
librium  association  constant  (KA) for  the  interaction  be- 
tween K b and 3-83 antibody was measured (Table  1).  Ap- 
propriate  control  antibodies  were  studied  in  parallel  to 
assure  the  specificity  of the  interaction  and  the  activity  of 
the  antibodies.  3-83  Fab binding  to  immobilized  K b dem- 
onstrated a very fast off rate (tl/2 ",'7.4 s) largely responsible 
for the low K^ value of 1.7  X  10 s M-1. Soluble K b binding 
to immobilized 3-83  was consistent with  this result, yield- 
ing a  K A value  of 3.3  X  105 M -1.  The bivalent,  IgG form 
of 3-83  bound  to  immobilized  K b  (K^  ~'-,5.5  X  106  M -1) 
with only  10-fold higher affinity than did F~b 3-83, whereas 
bivalency  improved  the  binding  of the  Y3  antibody  by 
>500-fold  (Table  1).  Consistent  with  the  binding  studies 
(Fig.  1),  the  monovalent  affinity  of 3-83  for  the  putative 
very low affinity ligand K bin3 was ~'-,10-fold lower:  KA "-'2  X 
104 M -1,  and the bivalent affinity was K A ,'-'5  X  10 s M -1 
This  binding  appeared  to  be  peptide  independent,  since 
m bin3 molecules were bound with similar affinities whether 
or not the groove-binding peptide was present. We refer to 
these weak interactions as ultralow affinities. 
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Concen- 
Ligand  Analyte  Valency  tration  k~ (M-is -1)  R.^2  Half-life  SD  k d (s-l)  SD  KA(M -1) 
S 
K b  Y3 IgG  Bi  62 nM  4.11E  +  05  4.21"  >3,600  2.43E-04  4.77*  1.7E  +  09 
K b  ....  3-83  IgG  Bi  800 nM  2.90E  +  04  0.991  135.3  28.1  5.29E-03  1.09E-03  5.5E  +  06 
K bin3  3-83 lgG  Bi  1,875 nM  1.42E  +  04  0.999  26.5  1.5  2.63E-02  1.61E-03  5.4E  +  05 
K6m3  ....  3-83  IgG  Bi  1,875 nM  1.25E  +  04  0.984  50.8  5.8  1.38E-02  1.73E-03  9.1E  +  05 
K b  ....  Hopc IgG  Bi  800 nM  No binding 
K bin3  Hopc IgG  Bi  3,500 nM  No binding 
Kbm3  ....  Hopc IgG  Bi  3,500 nM  No binding 
K t,  ....  3-83 Fab  Mono  8,000 nM  1.67E  +  04  0.93  7.4  2  9.98E-02  2.93E-02  1.7E  +  05 
K bin3  3-83  Fab  Mono  2,4450 nM  3.74E  +  03  0.977  3.2  0.8  2.27E-01  6.05E-02  1.6E  +  04 
Kbm3  ....  3-83 Fab  Mono  2,4450 nM  3.82E  +  03  0.979  5.1  1  1,40E-01  2.89E-02  2.7E  +  04 
54.1  3-83Fab  Mono  2,000 nM  4.12E  +  04  0.997  79.5  0  8.72E-03  0.00E  +  00  4.7E  +  06 
54.1  3-83  IgG  Poly  25 nM  6.57E  +  05  0.01"  NA  3.49E-04  0.07*  1.9E  +  10 
54.1  Y3 IgG  Poly  200 nM  No binding 
33.18.12  3-83Fab  Mono  1.40E  +  05  6.49*  NA  3.39E-06  2.77*  4.1E  +  10 
3-83  K b  ....  Mono  1,000 nM  1.42E  +  04  0.898  18.6  7.6  4.27E-02  1.83E-02  3.3E  +  05 
3-83  K bin3  Mono  4,140 nM  3.44E  +  03~  0.996  3.5  2.t  2.43E-01  t.47E-01  1.4E  +  04 
3-83  Kbm3  ....  Mono  9,140 nM  3.44E  +  03  0.996  13.1  1.2  5.31E-02  4.80E-03  6.5E  +  04 
Y3  K b  ....  Mono  500 nM  7.41E  +  04  0.966  30.4  3.1  2.30E-02  2.27E-03  3.2E  +  06 
Y3  K bin3  Mono  625 nM  2.03E  +  04  0.25*  25.9  4.3  2.74E-02  4.71E-03  7.4E  +  05 
Y3  Kbm3  ....  Mono  500 nM  3.52E  +  04  0.22*  16.8  2.2  4.19E-02  5.80E-03  8.4E  +  05 
Hopc  K b  ....  Mono  1,000 nM  No binding 
Hopc  K bin3  Mono  4,140 nM  No binding 
Hopc  Kbm3  ....  Mono  9,140 nM  No binding 
*The dissociation  rate was very slow disabling  regeneration of the chip.  Kinetic analysis is limited to one concentration  of analyte. The statistical 
analysis is the X  2  value for the regression analysis of the on and off rates. 
*The K~ vs. concentration plot did not generate a linear slope, therefore the A +  B =  AB regression model was used to calculate an on rate. The sta- 
tistical analysis is the X  2 value for the regression analysis of the highest concentration measured. 
gAssociation rate analysis for this experiment was uninterpretable, therefore the on rate for the K  bm3-v~v experiment was assumed to be comparable. As 
described in Materials and Methods,  the BIAcore was used to measure association  constants for divalent and  monovalent binding of Y3 and 3-83 
antibodies to soluble K b and K bin3 with and without peptide. The ligand refers to the protein bound to the sensor chip and the analyte the protein 
passed over the chip. The method for association  constant calculation is decribed in Matherials and Methods. The P,^2 and SD columns represent 
statistical analysis for ka and kd calculations,  respectively. The concentration column shows the highest concentration of analyte  evaluated.  Several 
rungs of two fold dilutions from this concentration were also evaluated. The irrevelant IgG2a Hopc-1  antibody was used to control for specificity. 
Binding of the 3-83 antibody to its anticlonotype 54.1 antibody was included as a positive control. Blank cells of the sensor chip were also used as 
negative controls. 
Immature B  Cells Bearing Ultralow Affinity Autoreactive  Re- 
ceptors for  Membrane-bound  Self-antigens  Are  "Deleted" from 
Peripheral Lymph  Organs.  To  ea~arnine the effect of the ul- 
tralow affinity ligands  on B  ceiltolerance,  3-83  1*/8  trans- 
genic  mice  were  bred  with  mice  that  expressed  these 
weakly reactive  class  I  haplotyes  (Fig.  2).  Transgenic  mice 
bred on  the non-3-83-reactive  H-2 a or H-2 f backgrounds 
had a nearly monoclonal population  of 3-83 idiotype-posi- 
tive  B  cells  in  the  peripheral  lymph  organs,  as  expected, 
whereas  idiotype-positive  B  cells  were  not  found  in  the 
lymph nodes or spleens ofF1  transgenic mice heterozygous 
for  K k,b,bm3,6,8,11  or  D k  alleles,  regardless  of the  affinity  for 
the 3-83  antibody  (Fig. 2  and Table 2).  Virtually no B220- 
positive,  IgM-negative  cells  were  present  (Table  2),  argu- 
ing  against  the  possibility  that  the  autoreactive  B  cells  had 
downregulated  surface  Ig  receptor  expression.  These  data 
demonstrate  that  even  ultralow  affinity,  membrane-bound 
self-antigens  are  capable  of "deleting"  autoreactive  B  cells 
from peripheral lymph organs. 
Uttralow  Affinity  Ligands  to  Autoreactive  ig  Receptors Are 
Capable  of Mediating  Receptor  Editing  in  Immature  B  Cells. 
To  determine  the  mechanism  by  which  3-83-bearing  B 
cells  were  absent  from  the  spleens  of F1  transgenic  mice 
that  expressed ultralow  affinity  ligands,  we used two  inde- 
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Figure  I.  Relative  binding of 3-83 antibody to various class I molecules in a flow cytometry assay. Binding of(A) 3-83 and (B) Y3 anti-class I antibod- 
ies to H-2 disparate, Sp2/0-derived hybridomas, or (C) binding of 3-83 antibody to spleen cells from MHC disparate mice. (D) Expands the lower range 
of the ordinate of C to differentiate poorly bound class I antigens. The data shown are representative of four independent experiments. 
pendent assays based on previous work (13)  to measure the 
extent  of receptor  editing.  Lymphocytes  from 3-83  trans- 
gene-positive,  H-2 heterozygous mice were double stained 
with  antibodies  specific  for  the  IgD  a (transgene-encoded) 
heavy  chain  and  k  light  chain.  This  assay identifies  trans- 
gene-bearing B cells that have undergone endogenous light 
chain gene rearrangements because the endogeneous heavy 
chain  antibodies  are  of the  b  allotype  and  the  3-83  trans- 
genic light chain is K. In transgenic mice of the H-2 f or H-2 a 
(nondeleting)  background,  the  vast majority  of B  cells ex- 
pressed the IgD ~ allotype  (Fig. 3 A  and summarized in Fig. 
3  B),  indicating  expression  of the transgenic  heavy  chain. 
These cells were not h-positive,  and anticlonotype  staining 
indicated  that  the  transgenic  heavy  chain  paired  with  the 
3-83  K light  chain.  But  in  the  presence  of autoantigen- 
expressing bone marrow,  regardless of the antigen affinities 
examined,  the  percentage  of cells  double-positive  for  the 
transgenic  heavy  chain  and  k  light  chain  was  significantly 
increased  (Fig.  3).  Because  the  total  spleen  cell  numbers 
among  H-2  disparate  mice  were  comparable  (data  not 
shown),  the  increased  percentage  of idiotype-negative  B 
cells in  the  presence  of antigen  represented  an  increase  in 
the absolute number of cells bearing these altered receptors. 
This  increase  in  IgD a,  k  double-positive  cells was not  ob- 
served  in 3-83  mice expressing a K b transgene  only in the 
periphery  (liver,  kidney;  21;  Fig.  3  B  column  marked  Per 
and reference 13), demonstrating that the abundant k-positive 
B  cells  found  in  the  centrally  deleting  mice  were  antigen 
induced  and not merely the outgrowth  of preexisting vari- 
ants. 
Evidence for receptor editing was also apparent in assays 
that measured expression levels in the bone  marrow of the 
V(D)J  recombinase  genes  RAG-1  (56)  and  RAG-2  (57). 
As  observed  previously  (13),  H-2 d  3-83  Ix/~  transgenic 
mice expressed a low level of RAG-2,  consistent with the 
observation  that  endogenous  Ig  rearrangements  are  sup- 
pressed  by  expression  of the  transgenic  receptor  (Fig.  4). 
Breeding of the 3-83  p,/8 transgenic mice onto  class I hap- 
lotypes that were even weakly reactive with the 3-83  anti- 
body  resulted  in  significant  upregulation  of the  RAG-2 
gene  expression,  relative  to  that  observed  on the  nonreac- 
tive H-2  d backgrounds  (Fig.  4),  again suggesting that these 
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Figure 2.  Deletion ofidiotype-positive B cells from spleens of 3-83 b~/8 transgenic mice expressing low affinity self-antigens. 3-83 Iz/8 transgenic mice 
from H-2 a ×  H-2 x breedings (x -- haplotype including k, b, b mutations, d, and f) were killed at 2-4 mo of age. Spleen cells were stained with biotiny- 
Iated anticlonotype 54.1 antibody and FITC rat anti-mouse igM antibody. 54.1 binding was revealed with PE-streptavidin. Each row represents an inde- 
pendent experiment and is representative of a minimum of three experiments for each H-2 haplotype. 
low  affinity ligands  can induce  receptor  editing.  Similar re- 
sults  were  obtained  in  assays  of  RAG-1  levels  (data  not 
shown).  In contrast,  little or no increase  in RAG-2  expres- 
sion  was  observed  in  mice  beating  the  MT-K  b  transgene, 
which  restricts K b antigen  expression  to extra bone  marrow 
tissues  and demonstrated  little endogenous  light chain  rear- 
rangement  (Fig.  3  B).  Taken  together  with  the  changes  in 
levels  of  spleen  IgDVX  double-positive  cells,  these  data 
Table  2.  Deletion  of ldiotype-positive B CelIs  from Peripheral Lymph Organs of (3-83 × H-2  x) FI Transgenic  Mice 
Percent of 54.1 ÷ cells 
3-83 transgenic mice 
H-2 haplotype (FI)  Lymph node  Spleen  Bone marrow  Lymph node 
Percent orB220 + cells 
Spleen  Bone marrow 
d  16.6  +  1.2"  (18)*  39.3  +  1.3  (19)  27.0  +  1.8  (11) 
k  0.2  +  0.2  (3)  0.3  _+ 0.2  (3)  0.1  ___ 0.1  (2)g 
b  0.1  +  0.1  (8)  1.1  ___ 0.5  (10)  2.7  +  2.3  (8).~ 
bm3  0.1  +  0  (7)  0.4  +  0.2  (7)  2.1  +  1.9  (4)$ 
bm6  0  +  0  (4)  1.2  +  0.3  (4)  ND 
bm8  0.2  _+ 0.1  (6)  1.4  +  0.6  (6)  2.8  +  2.7  (2)~ 
bm11  0  +  0  (4)  0.9  +  0.9  (4)  3.1  +  0.9  (3)5 
KdD k  0  ±  0  (6)  0.5  +  0.2  (5)  2.4  _  2.1  (2)5 
Nontransgenic  mice  0.3  +  0.1  (15)  0.7  _  0.2  (15)  0.3  +  0.1  (9) 
13.4  +  1.2  (17) 
5.4  +  3.4  (2) 
2.2  +  0.8  (7) 
2.4  ___ 0.5  (6) 
1.9  +  0.3  (4) 
2.8  +  0.4  (6) 
3.9  _  0.5  (4) 
0.9  ±  0.1  (6) 
23.1  +  2.0  (15) 
36.1  +  1.5  (I8)  26.7  +  2.0  (8) 
10.0  +  3.9  (2)11  26.5  ±  7.5  (2) 
7.9  ___ 0.8  (9)Jr  36.9  ___ 2.0  (5) 
8.6  +  1.7  (6)1t  35.9  +  5.6  (3) 
17.3  +_ 2.8  (3)ll  31.7  (1) 
14.6  +  2.0 (6)ll  ND 
13.9  ±  3.0 (4)IP  35.4  +  0.7 (2) 
7.4  +  0.6 (6)11  41.0 (1) 
40.8  ±  2.8  (15)  52.8  +  4.9  (6) 
*Data are mean _4- SEM of three to six experiments. 
*Numbers in parentheses indicate number of rrfice examined. 
~The lower percentage of id-positive cells is primarily the result of receptor downmodulation,  which prevented detection at the concentration of 
54.1  used. 
ElThese cells coexpressed IgM receptors and are presumably the result of receptor editing. 
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Figure  3.  Increased  percent- 
age of B cells coexpressing lgD  ~ 
(transgene  heaw  chain)  and  X 
light  chain  (endogeneous)  in 
spleens  of  autoantigen-bearing 
transgenic mice.  (A) Spleen cells 
from 3-83  transgenic  mice bred 
with  non-antigen  bearing  mice 
(H-2  ds)  or  antigen-expressing 
mice  (K b'bm3'bmll  or  D k)  were 
stained with FITC anti-X and bi- 
otinylated  anti-lgD  ~ antibodies, 
followed  by  PE-streptavidin. 
On  these  genetic  backgrounds, 
only the transgenic  hea  W  chain 
is of the 'a' allotype. A nontrans- 
genic control is included to show 
specificity of the 'a' allotype re- 
agent for transgene.  50,000  cells 
from each sample were collected 
in a gate defined by forward and 
side scatter  to  include  the  pre- 
dominant  lymphocyte  popula- 
tion.  Each  row  represents  an 
individual experiment and is rep- 
resentative  of  a  minimum  of 
three experiments for each  H-2 
haplotype.  (B)  The  combined 
data are  shown  as  the  mean  + 
SEM  (error  bars)  percent  of 
lgD  ~,  R double-positive cells in 
transgenic  mice of the indicated 
H-2  haplotype.  The  number 
above  each  bar  indicates  the 
number of mice per group. Per, 
peripherally deleting, MT-Kb/3  - 
83  bt/8  double-transgenic mice; 
Non  Tg,  nontransgenic  litter- 
mates. 
demonstrate  the  ability of even  ultralow affinity ligands  to 
fully  induce  central  tolerance  and  receptor  editing  in  au- 
toreactive B  cells. 
In Acute  Challenge with Antigen,  Ultralow A[~nity Ligands 
Are  Only  Moderately Effective at  Deleting  Mature  B  Cells as 
Compared to the  "High" Afllnity i~ Ligand.  To  test the  ef- 
fect  of the  receptor/antigen  interaction  on  tolerization  of 
mature  B  cells,  we  took  advantage  of a  system  originally 
described  by  Murakami  et  al.  in  which  it was  shown  that 
ligands of surface Ig could induce rapid apoptosis of perito- 
neal B  cells  (9,  22,  58).  We  injected mice intraperitoneally 
with  Sp2/0  (H-2d)-derived  cell lines coexpressing the  fol- 
lowing  class  I  molecules:  K k,  K b,  K urn11, and  K um3, which 
bind  3-83  with  decreasing  affinities.  Approximately  16  h 
later,  the  peritoneal cavity  cells were  isolated  and  deletion 
of  the  id-positive  B  cells  was  scored.  The  Sp2/0  (H-2  d 
control)-injected  mice  generally  showed  a  modest,  non- 
antigen-specific  reduction  in  transgenic  B  cells  compared 
to PBS-injected  controls  (Fig.  5, A  and  B).  In contrast,  in- 
jection  of the  high  affinity  Kk-expressing  tumors  led  to  a 
consistent 5-10-fold  decrease in  the percentage  of id-posi- 
tive  B  cells  over  eight  experiments  (Fig.  5  and  Table  3). 
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Figure 4.  Elevated expression of RAG-2 in the presence of bone mar- 
row  autoantigen, including low affinity ligands. Reverse  transcription 
PCIK analysis of bone  marrow  RNA of (3-831*8 Tg/H-2  x)  [:1  mice, 
where x includes H-2 haplotypes  both reactive  and nonreactive to the 3-83 
antibody, cDNA was amplified with 17-22 cycles of PC1K using oligos 
specific for IKAG-2 and, as a normalization control, the ubiquitously ex- 
pressed GTP-binding protein, Gas. Southern blot analysis  revealed speci- 
fic fragments that were quantitated using a Phospho-y-imager. The data 
represent the  mean +  SEM  RAG-2/Gots  values for  each haplotype. 
Numbers of mice per group are shown above each bar. 3-831xg/MT-K  b 
peripherally deleting mice (Per T2), in which K  b antigen driven by the 
metallothionein promoter  is expressed in the periphery, but not in the 
bone marrow, are included as negative controls for the nonspecific effects 
of peripheral B cell deficiency (13, 21). Results with nontransgenic mice 
(Non Tg) define normal levels of bone marrow RAG-2 expression. 
The  remaining id-positive B  cells usually showed  down- 
regulation of IgM receptor expression, indicating that these 
cells had  encountered  antigen  (Fig. 5  A).  To  exclude the 
possibility that the B  ceils completely lost their receptor ex- 
pression and thus were not actually deleted, cells were dou- 
ble stained with anti-IgM and anti-B220 antibodies. As can 
be seen in Table 3,  no increase in the percentage of IgM- 
negative, B220-positive cells accompanied the  decrease in 
id-positive B  cells. Based  on  the  previous work,  we  pre- 
sume  the id-positive cells that  disappeared had undergone 
antigen-induced apoptosis and had not merely left the peri- 
toneal  cavity (9,  22,  58).  This  deletion effect induced  by 
the  intraperitoneal injection  of antigen was  not  seen  sys- 
temically, since no  change  in the percentage  (or number) 
of splenic transgenic B  cells was observed (Table 3). 
Having shown deletion of reactive, matureB  cells upon 
injection of high affinity K k ligand, we tested the sensitivity 
of this tolerance mechanism to the antibody/antigen-bind- 
ing  affinity.  Intraperitoneal  injection  of the  low  affinity 
(K  b)  and  ultralow  affinity  (K  bm3,11) ligand-expressing cell 
lines resulted in only twofold reduction of the 3-83-bear- 
ing B-cells (Fig. 5  and Table 3).  Compared to Kk-injected 
cells, the amount  of deletion with  the lower affinity anti- 
gens  was  less  consistent  over  several  experiments,  and 
downregulation of the IgM receptor was rarely seen. Over- 
all, a difference in the extent of deletion of mature B  cells 
upon acute antigenic challenge was clearly noted between the 
high affinity K k molecule and the lower affinity K b,bm3,b'ml 
ligands, whereas even these weakly reactive molecules were 
capable of inducing complete deletion of immature, autore- 
active B  cells, as was clear from analysis ofF 1 crosses (Fig. 2 
and Table 2). 
Discussion 
In concordance with earlier studies investigating the sen- 
sitivity ofB ceU torrance with respect to BCR/soluble an- 
tigen affinity (31,  32,  36),  we  have  verified tolerance  in- 
duction  in  immature  B  ceils  upon  interaction  with  very 
low affinity, membrane-bound self-antigens. We were able 
to follow the fate of the immature, self-reactive B  cells and 
to show that deletion of this cell population was indeed the 
mechanism  of censorship.  Our  data also  indicate that  ex- 
tremely low affinity membrane ligands are sufficient to sig- 
nal the  immature  B  ceil to  alter receptor specificity ("re- 
ceptor editing"). 
In this study, the affinity between MHC  class I autoanti- 
gen and Ig receptor that was sufficient to stimulate receptor 
editing/deletion of the immature B  cell was so low that we 
were unable to place a lower limit on its value. In two in- 
dependent studies, we measured the affinity constant of the 
monovalent interaction between K b and 3-83 to be in the 
range ofl-3  ×  10 s M -1. K bin3 and D k were bound by 3-83 
more  weakly than  K b,  requiring more  than  10-fold more 
IgG to achieve similar binding. Because these ultralow af- 
finity ligands were fully as effective as high affinity ligands 
in  mediating central deletion,  an  affinity constant  of 4  X 
104 m -1 between BC1K and membrane self-antigen repre- 
sents  a  very conservative value  sufficient to  induce  toler- 
ance in the immature B  cell population, this range of affin- 
ity was  in  fact  observed in  the  case  of K bin3 (1-6  X  104 
M-l). This affinity is lower than many reported for TCR/ 
class I peptide agonist interactions (59), suggesting that cen- 
tral deletion ofautoreactive B  cells in the bone marrow can 
be as sensitive as central T  cell tolerance and indeed is in 
the affinity range for positively selecting ligands (60). 
An important implication of a low affinity threshold for 
self-tolerance is that it may have profound effects on the B 
cell repertoire and directly influence the fate of a large pro- 
portion  of generated  B  cells.  Theoretical  models  predict 
that  self-reactivity should  be  common  in  the  preselected 
lymphocyte repertoire and that negative selection may play 
a powerful role in the evolution of lymphocyte specifc- 
ity (61). 
While the multivalent nature of the cell/cell interactions 
between the B  cell and antigen-bearing cells is important in 
permitting weak interactions to lead to biologically signifi- 
cant avidities, such  multimerization does not make recep- 
tor/ligand affinity irrelevant. Analysis of peripheral B  cell 
tolerance using the same panel ofligands that led to central 
tolerance revealed clear differences between  high and low 
affinity ligands in the efficiency of peripheral deletion. 
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Figure 5.  Reduction ofidiotype-positive  cells in the 
peritoneal  cavity  of transgenic  mice  upon  antigenic 
challenge.  Nondeleting (H-2  d)  3-83  transgenic mice 
were  injected  intraperitoneally  with 5  ×  106 MHC- 
disparate Sp2/0 spleen hybridomas. Sp2/0 (H-2  d) cells 
were  injected to control for antigen nonspecific effects 
and one mouse per group received 100 ~tl of PBS alone. 
(A) Approximately 16 h after injection, nucleated peri- 
toneal cells were isolated and stained with biotinylated 
antidonotype 54.1 and FITC-labeled rat  anti-mouse 
IgM antibodies. Biotin-conjugated 54.1 was  revealed 
with PE-streptavidin.  Fluorescence analysis was gated 
by forward and side scatter to exclude the large mye- 
loid and injected tumor cells. The density plot data are 
from  one experiment  and represent  six such  experi- 
ments. (/3) The compiled data as the percentage of id- 
iotype-positive cells (quadrant 2) in the peritoneal cav- 
ity after injections of cell lines. The letter on the x axis 
indicates the H-2 haplotype of injected cells. The data 
are mean -+ SEM for each group. The number of mice 
in each group is indicated above each bar. 
An unexpected finding in the present study was that the 
IgG form  of the  3-83  antibody had  only a  slightly higher 
overall avidity for immobilized ligand than the correspond- 
ing  F,b  fragment.  The  comparative  increase  seen  in  the 
bivalent vs. monovalent binding of the Y3 antibody to the 
same class I ligand was more than 500-fold and was consis- 
tent  with  results  from  previous  studies  on  affinity  con- 
stants  for  anti-class  I  antibodies  to  their  ligands  (62), 
whereas  the  affinity increase resulting from bivalent bind- 
ing in the  3-83/Kb  interaction was  unusually small.  Since 
Y3 and 3-83 were passed over the same KU-containing sen- 
sor chip,  a  density difference resulting in spatial limitations 
could not account for  this  difference,  particularly because 
Y3 and 3-83 reportedly see the same epitope  (53).  Impor- 
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tantly,  there  was  excellent  agreement  between  measured 
affinities  of the  IgG  antibodies  and  the  relative  affinites 
observed in the flow cytometry analysis of binding to Kb- 
expressing cells: ~l,000-fold  higher concentration of 3-83 
was required to achieve levels of binding equivalent to that 
observed with Y3  (Fig.  1).  These  findings lend credibility 
to the extreme sensitivity of B  cell tolerance induction with 
respect to affinity, since the polyvalency appeared to play a 
limited role in this particular Ig transgenic system. 
Because  of the peptide  dependency of some anti-class I 
antibodies (63), it is difficult to formally exclude the possi- 
bility that the weak binding ofD k and K bm3 ligands by 3-83 
actually represents  expression of a  lower density of higher 
affinity ligands rather than a  comparable density of low af- Table 3.  Degree  of Reduction in the Number of ldiotype-positive B Cetts  from the Peritoneum of Antigenically Challenged Transgenic 
Mice Correlates with Ad~nity of 3-83 Antibody for Antigen 
Peritoneal exudate cells  Spleen cells 
H-2 (X ×  d) of  %B220 +, 
injected cells  %54.1 +  %IgM +*  %B220 +*  IgM-  %54.1 +  %IgM +  %B220 + 
d  11.2  +  1.2¢ (7)~  23.2  _  6.7 (6)  15.4 +  2.5 (6)  2,2 ___ 0.5 (4)  48.6  -+ 4.7 (5)  53.1  _  2.9 (4)  49.1  __ 3.7 (4) 
k  1,8 ___ 0,2 (8)  7,8  ±  1.1  (8)  8.4 _-+  1.0 (8)  2.2 +  0.3 (5)  48.3  +  6.3 (5)  52.3 +  5.9 (4)  49.9 +  6.0 (4) 
b  6.1  ___  1,6 (6)  14.2  +  5.2 (5)  11.7  +__ 3.1  (5)  2.6 +  0,6 (4)  41.5  +  2.4 (5)  50.2  +  3,2 (4)  48.5  +  3.2 (4) 
bin3  5.4 ___  1.0 (6)  14.6  +  2.6 (6)  10.7 _-+  1,9 (6)  2.0 +  0.5 (5)  44.9 --- 4,1  (4)  54.3  +  0.5 (3)  52.8  --- 2.0 (3) 
bin11  7,0 +  1.1  (6)  16,4 +  4.3 (6)  11.4  __- 2.4 (6)  1.5  +  0,3 (5)  34,8  -  7.9 (3)  48.1  +  2.7 (3)  48,4 -  2,4 (3) 
pbs  15.2  +  2,1  (6)  26.0 +  3.8 (5)  i8.3  +  2.4 (5)  1,3  +  0.4 (3)  38.3  -- 3.3 (5)  42.1  +  0.5 (3)  41.2  +  2.0 (3) 
*The peritoneal cells consist of a variable population oflgM +, B220 -/l° cells, which are not gated as B220  + cells, and account for the discrepancy be- 
tween the percentage of lgM + and B220 + cells. 
*Data are mean _  SEM. 
~Numbers in parentheses represent number of mice examined. 
finity ligands.  We  do  not  favor  this  notion,  however,  be- 
cause it is inconsistent with the observation that binding to 
putative  tow  affinity  ligands  fails  to  plateau  at  high  3-83 
concentrations  (Fig.  I  D)  and the similar binding affinities 
of 3-83  to  peptide-bearing  and  peptide-free  K bin3. None- 
theless, if the weak binding to certain class I molecules such 
as D k does represent a low density of high affinity antigens, 
the  interpretation  of our data would be  that  tolerance  can 
be induced by higher affinity membrane antigens present at 
very low  epitope  density,  as opposed  to  the interpretation 
that we favor, namely that tolerance is induced by very low 
affinity  self-antigens  with  moderate  to  high  cell  surface 
abundance. We have attempted to address the issue of anti- 
gen  density  by  breeding  ~32-microglobuhn-deficient  mice 
with  3-83  transgenic  mice  bearing  H-2 bin3.  The  F I  mice 
expressed one  half the  normal class  I molecules because  of 
heterozygosity  of the  132-microglobulin  locus  deficiency, 
and  only  one  half of the  H-2 k molecules  were  antigenic 
(Kbm3), since the mice were heterozygous  at the MHC  lo- 
cus (bm3/d). With one quarter the normal number of class I 
molecules,  the  resulting  transgenic  mice  were  still  capable 
of fully  deleting the  autoreactive  B  cells  and  inducing  re- 
ceptor editing (data not shown), suggesting that only a few 
thousand  molecules  per  cell  of a  low  affinity  membrane 
self-antigen,  when  present  in  the  bone  marrow,  can  effi- 
ciently induce B  cell tolerance. 
The possible peptide dependency of anti-class I antibod- 
ies  also  presents  limitations  to  our  affinity  measurements, 
since  the  recombinant  soluble  H-2 k molecules  contained 
only  one  or  a  bruited  number  of peptides.  However,  the 
binding affinity measurements correlated well with binding 
of these antibodies to spleen or hybridoma  cell-derived K b 
molecules, which bear diverse peptides. 
Do  weakly  self-reactive B  cells  contribute  to  the  emer- 
gence of low affinity autoantibodies?  In contrast to  the af- 
finity studies in the HEL radiation chimera system (36), we 
do not see the emergence of 3-83-bearing ceils in F1  trans- 
genic  mice  on  any  low  affinity  D k,  K bm3, or  K bin11 back- 
ground  in  mice  tested  out  to  18  mo  of  age  (data  not 
shown).  Nevertheless,  B  cells  with  low  af[ini W  receptors 
may  be  more  sensitive  to  a  breakdown  in  tolerance.  Al- 
though  all  of the  ligands  of 3-83  that  we  tested  induced 
central  deletion,  it  is  likely  that  there  exists  an  affinity 
threshold  for  membrane  antigen  at  which  the  reactive  B 
cell is no longer tolerized or the tolerance phenotype  is al- 
tered, perhaps leading to an anergic state rather than to cell 
death.  We have evidence for this change in tolerance phe- 
notype  to  a  membrane-bound  antigen  in  cases  of limiting 
antigen  dose  (our  unpublished  data),  implying  that  the 
strength of the tolerance signal is dependent on the number 
or duration of B  cell/antigen interactions.  It will be impor- 
tant to determine if a low affinity ligand requires longer du- 
ration or more antigenic "hits" for a tolerance signal to sat- 
isfy a miminum threshold for tolerance. 
Developing  B  cells  are  generally  thought  to  be  more 
sensitive to tolerance induction than mature B  cells (1, 64), 
but this is by no means proven (32). Our data are consistent 
with,  but  do  not  prove,  this  notion,  since  deletion  of the 
autoreactive  mature  B  cells  occurred  consistently  only  in 
the presence of the high affinity K k ligand. The  intermedi- 
ate  affinity,  K b,  and low  affinity  K bin3,11 ligands  were  only 
able to induce partial deletion, suggesting that low affinities 
(< 106 M -1) limit the potential to induce deletion. A differ- 
ence in total H-2 k density could not account for this differ- 
ence  in  deletion  induction,  since  staining  of the  hybrido- 
mas  showed  equivalent  surface  expression.  In  contrast  to 
the  partial  deletion  seen  upon  intraperitoneal  injection  of 
K u cells into  3-83  p~/8  mice,  transgene-driven,  tissue-spe- 
cific expression of the intermediate affinity ligand K b on the 
liver and kidney  results in  complete deletion  of the  3-83- 
beating B  cells from the lymph node in MT-KU/3-83  bt/8 
double-transgenic  mice  (21).  The  inability  of Kb-bearing 
cells to achieve the same level of deletion upon intraperito- 
neal injection  could be  caused by  the  more mature  devel- 
1694  B Cell Tolerance to Ultralow Affinity Antigen opmental state of the B  cells that encounter autoantigen in 
this  case,  or  because  of a  longer  duration  of exposure  to 
antigen  in  the  double-transgenic  mice,  compared  to  the 
short-term  peritoneal  injection  assay.  No  increase  in  the 
deletion of transgenic B  cells was observed 2 d  after perito- 
neal  injection  of Kb-hybridomas,  suggesting that a  longer 
period  of antigen  exposure  did  not  affect  the  phenotype, 
but further experiments are required to establish this point. 
An  important conclusion  to be drawn  from our study 
is  that  tolerance  to  membrane  self-antigens  can  be  extra- 
ordinarily  efficient,  and  can eliminate  precursors  of anti- 
body-forming cells that have very low affinity for self. This 
tolerance may be  essential to  the  survival  of the  organism 
because low affinity IgM antibodies to cell-surface proteins 
are potentially toxic,  as has been  observed in  tissue rejec- 
tion by isoantibodies (65, 66). In view of these efficient tol- 
erance  mechanisms,  one  might  ask  how  autoantibodies 
arise.  One  clue  from  the  present  study  is  the  apparently 
higher affinity threshold for the deletion of mature B  cells, 
at least in response to transiently expressed antigen. Perhaps 
failure in these mechanisms resulting from stricter require- 
ments for tolerance induction in mature B  cells contribute 
to the autoimmune process for peripheral antigens. 
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